Severe complications after transcatheter arterial chemoembolization for hepatocellular carcinoma
Cui Yanfeng
Abstract
Cui Yanfeng
Abstract
Objective To evaluate the severe complications of transcatherter arterial chemoembolization (TACE) for hepatocellular carcinoma (HCC). Methods The recent severe complications of 1000 times TACE for 556 patients with HCC were retrospectively analyzed. Results The recent severe complications of TACE included massive upper gastrointestinal hemorrhage (3/1000, 0.3%), liver failure (26/1000, 2.6%), pulmonary lipiodol embolism (5/1000, 0.5%), cerebral lipiodol embolism (2/1000, 0.2%) and liver abscess (2/1000, 0.2%). Conclusion The severe complications of TACE for HCC will influence the prognosis and should be noticed.
OpenAlex reports 2 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To evaluate the severe complications of transcatherter arterial chemoembolization (TACE) for hepatocellular carcinoma (HCC). Methods The recent severe complications of 1000 times TACE for 556 patients with HCC were retrospectively analyzed. Results The recent severe complications of TACE included massive upper gastrointestinal hemorrhage (3/1000, 0.3%), liver failure (26/1000, 2.6%), pulmonary lipiodol embolism (5/1000, 0.5%), cerebral lipiodol embolism (2/1000, 0.2%) and liver abscess (2/1000, 0.2%). Conclusion The severe complications of TACE for HCC will influence the prognosis and should be noticed.
Key concepts: Medicine, Lipiodol, Hepatocellular carcinoma, Transcatheter arterial chemoembolization, Embolization, Radiology, Pulmonary embolism, Liver abscess